Nothis was an advisory recommendation No
Many of these are peptides that BHRC has extensive clinical experience with: BPC-157 (Body Protection Compound) Often called the Wolverine peptide for its potential regenerative properties, BPC-157 has been one of the most sought-after compounds in functional medicine
Colchicine is one of a small number of drugs where new studies were done (for example, of drug interactions and re-evaluation of dosing) where the FDA has granted brand status to a manufacturer despite the unbranded form having long been available
However, BPC-157's regulatory status is complex and may vary by use, jurisdiction, and product category - including FDA regulatory and safety concerns regarding certain BPC-157-related bulk substances used in compounding contexts
semaglutide base creates different legal considerations Quality varies dramatically between compounding pharmacies Many compounding operations are actually importing raw ingredients from China with questionable quality As of February 2026, the regulatory landscape continues to shift
